(RTW) |
| 0 (0%) 04-16 06:24 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 7.15 |
| Resistance 1: | 6.12 |
| Pivot price: | 5.71 |
| Support 1: | 5.55 |
| Support 2: | 5.19 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.630 |
| Book Value | 7.360 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.048 |
| Profit Margin (%) | -39.48 |
| Operating Margin (%) | 32.13 |
| Return on Assets (ttm) | -0.3 |
| Return on Equity (ttm) | -6.4 |
Company news
Wed, 15 Apr 2026
RTW Biotech rises as cancer therapy firm agrees to reverse merger - London South East
Mon, 13 Apr 2026
Creased Ease Fall 2026 RTW Fashion Trend - The Impression
Mon, 30 Mar 2026
RTW Biotech says prospects are "compelling" as drug developers begin “a new phase of maturity” - QuotedData
Fri, 20 Feb 2026
Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch - Fierce Biotech
Thu, 05 Feb 2026
In Pictures: J. Lindeberg unveils its first women's RTW collection - fashionunited.uk
Thu, 05 Feb 2026
Right to work (RTW) checks set to extend beyond "employees" - Dentons
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
